HAJO GRUNDMANN – GERMANY
Hajo Grundmann, born in 1955, studied Sinology, Nursing and Human Medicine at the Universities of Bochum and Freiburg, Germany. He specialised in Clinical Tropical Medicine, Medical Microbiology and Hygiene & Environmental Medicine and received his PhD at the University of Freiburg, Germany and an MSc in Epidemiology of Communicable Diseases at the London School of Hygiene. He worked clinically as a medical doctor at university hospitals in Freiburg, Berlin, and Nottingham and carried out extensive field studies in Taiwan, Venezuela and Tanzania. For eight years, he was leading the European Antimicrobial Resistance Surveillance System (EARSS) funded by the European Commission and the Dutch Ministry of Health as the Head of Department for Microbiology at the Dutch National Institute for Public Health and the Environment (RIVM). Currently, he is the Director of the Institute for Infection Prevention and Hospital Epidemiology at the Medical Centre – University of Freiburg, Germany. He also holds the Chair for Infectious Diseases Epidemiology at the University of Groningen. His major research interests are the molecular evolution, epidemiology, population dynamics and health impact of emerging antimicrobial resistance and health care associated infections. – Address: University Medical Centre Freiburg, Faculty of Medicine, University of Freiburg, Breisacherstr. 115b, 79106 Freiburg, Germany.

 
 

MARC BOURLIÈRE – FRANCE
Marc Bourlière , received his medical degree in 1987 from Marseilles University in Marseille, France. He completed his fellowship training at Marseilles University hospital and in Beaujon University hospital in Paris. He was assistant in Hepatology in Conception University hospital in Marseilles before taking up his current position as head of the Hepato-Gastroenterology department at Hospital Saint Joseph also in Marseilles. He has been appointed Associate Professor at Paris Hospital Medical College.
Dr Bourlière andhis group have participatedin hepatitis B and C and HCC clinical trials; His research focus were the use and development of non invasive biomarkers in hepatitis and is more currently development of new antiviral therapy for hepatitis C, B.
Dr Bourlière has published more than 300 papers or chapters in international journals and books focused on hepatitis B and C. As well as reviewing for many specialist journals, he hasserved as member of the editorial board of Gastroenterologie, Clinique and Biological.
Dr Bourlière belongs to the French Agency for AIDS and hepatitis research (ANRS) and he co chair the ANRS group that coordinates hepatitis clinical therapeutic trials (CSS13). He belonged to the scientifc committee of the HEPATHER cohort. He is also member of several professional societies including the French (AFEF), the American association for study of liver disease (AASLD) and the European associations for the study of the liver (EASL).

 
 

MICHEL CLAUDIO NUSSENZWEIG – USA
Michel Nussenzweig is the Zanvil A. Cohn and Ralph M. Steinman Professor and a Howard Hughes Investigator at the Rockefeller University.
Dr. Nussenzweig received his MD degree from NYU Medical School and his PhD from Rockefeller University for work with Ralph Steinman on Dendritic Cells. Together with Steinman he showed that Dendritic Cells are antigen presenting cells a discovery that led to the 2011 Nobel Prize for Steinman. Dr. Nussenzweig completed training in Medicine and Infectious Diseases at the Massachusetts General Hospital before joining Phil Leder for a postdoctoral fellowship at Harvard Medical School. With Leder he began to work on antibodies and he continued in that line of research upon returning to Rockefeller University as an independent investigator in 1990.
Dr. Nussenzweig is known for his work on Dendritic Cells and on the development of antibodies and B-lymphocytes. He chairs the editorial board of the Journal of Experimental Medicine, is a member of the US National Academy of Sciences, the US National Academy of Medicine, the American Academy of Arts and Sciences, the Spanish Royal Academy and the Brazilian Academy. Dr. Nussenzweig if the winner of numerous awards and prizes most recently the 2016 Robert Koch award and the 2017 Pasteur Sanofi award.

 
 

MITCHELL J. SCHWABER – ISRAEL
Professor Schwaber is the director of the National Center for Infection Control of the Israel Ministry of Health in Tel Aviv. A native of Boston, USA, he pursued his medical studies at the Albert Einstein College of Medicine in New York, medical residency at Massachusetts General Hospital in Boston and Hadassah University Hospital in Jerusalem, Israel, and training in infectious diseases and epidemiology at Beth Israel Deaconess Medical Center and the Harvard School of Public Health, in Boston.
In addition to his duties with the Ministry of Health, he practices internal and infectious diseases medicine at Tel Aviv Sourasky Medical Center and Maccabi Healthcare Services, is Professor of Medicine at the Sackler Faculty of Medicine at Tel Aviv University, and is a reserve officer in the Medical Corps of the Israel Defense Forces. His primary research interest is the epidemiology of antimicrobial resistance in healthcare-associated bacteria.
He lives in Modiin, Israel, with his wife and three daughters.